{"id":28335,"date":"2022-06-15T11:19:12","date_gmt":"2022-06-15T06:19:12","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=93392"},"modified":"2022-06-15T11:19:12","modified_gmt":"2022-06-15T06:19:12","slug":"allmed-becomes-the-first-fully-mdr-compliant-haemodialysis-product-producer-in-europe-the-middle-east-and-africa-emea-region","status":"publish","type":"post","link":"https:\/\/myanmarnewsgazette.com\/allmed-becomes-the-first-fully-mdr-compliant-haemodialysis-product-producer-in-europe-the-middle-east-and-africa-emea-region\/","title":{"rendered":"Allmed becomes the first fully MDR compliant haemodialysis product producer in Europe, the Middle East and Africa (EMEA) region"},"content":{"rendered":"
Allmed becomes the first fully MDR compliant haemodialysis product producer in Europe, the Middle East and Africa (EMEA) region<\/strong><\/p>\n LONDON, UK<\/strong>; <\/strong>15<\/strong> June<\/strong>,<\/strong> 2022<\/strong> \u2013 Allmed Medical GmbH, part of Allmed Group (\u201cAllmed\u201d or \u201cthe Company\u201d), a producer of end-to-end haemodialysis solutions, today announces that it has received Medical Device Regulation (EU MDR 2017\/745) certification from its Notified Body, the British Standards Institution (BSI), ensuring continuous market access of the Company\u2019s haemodialysis products in Europe.<\/p>\n With the certification, Allmed has become the first haemodialysis products producer in the EMEA region to accomplish and certify full MDR compliance on its medical devices.<\/p>\n Ahmed<\/strong> Sorour<\/strong>, Chief Executive Officer<\/strong> at <\/strong>Allmed<\/strong> Group<\/strong>, said:<\/strong> \u201c<\/em>Allmed\u2019s mission is to<\/em> make<\/em> a <\/em>meaningful<\/em> difference <\/em>to<\/em> people<\/em> living on dialysis and <\/em>receiving MDR certification<\/em> means that we will continue to <\/em>do so.<\/em> Becoming<\/em> the first fully compliant haemodialysis product producer in<\/em> the EMEA region is a testament<\/em> to <\/em>our<\/em> commitment to deliver<\/em>ing<\/em> high quality, safe solutions to haemodialysis patients<\/em>, and I am <\/em>proud of<\/em> the<\/em> many <\/em>months of hard work<\/em> and commitment<\/em> by Allmed<\/em>\u2019s Total Quality Management<\/em> team.\u201d<\/em><\/p>\n Haydar Jaafar<\/strong>, <\/strong>Operations Delivery Director<\/strong> at BSI, commented:<\/strong> \u201cWe are delighted to issue the essential MDR certificates to Allmed Medical GmbH, who have prioritised working to the new, more stringent MDR requirements. This achievement is a testament to their commitment to ensuring innovation remains at the forefront of their product development. These life-saving products will support patient safety at a critical time and are a sign of the resilience of our industry.\u201d<\/em><\/p>\n The certificate, valid until 2027, will be officially registered on the European Database of Medical Devices and covers the following product groups, which are major components of Allmed\u2019s dialysis portfolio:<\/p>\n Additionally, Allmed has successfully passed all MDR-related Quality Management System (QMS) audits and has been granted the corresponding certificate (BS EN ISO 13485:2016+A11:2021) valid until 2025.<\/p>\n About Allmed Group <\/strong><\/p>\n Allmed Group is a global producer of end-to-end haemodialysis product solutions. It is headquartered in London and has product development and manufacturing operations in Germany and in Egypt. In addition, it has direct sales, marketing & distribution operations in the UK, Brazil, Egypt, Turkey, Poland, Germany and India. The Group employs more than 1,300 staff world-wide and exports to more than 40 countries across the globe.<\/p>\n About European Medical Device Regulation (MDR)<\/strong><\/p>\n The MDR 2017\/745 came into effect in May 2021, replacing the former European Directives for medical devices (AIMDD 90\/385\/EEC and MDD 93\/42\/EEC). It is intended to establish a robust, transparent, predictable and sustainable regulatory framework for medical devices to ensure a high level of safety and health whilst supporting innovation. EU MDR has significantly increased the requirements in respect of technical documentation, risk management approach, benefit-risk evaluation, Unique Device Identification (UDI), Economic Operators, clinical evaluation, vigilance, trend reporting and post-market surveillance, with more stringent scrutiny of Competent Authorities and Notified Bodies. It represents the biggest change in European medical device compliance standards in more than 20 years.<\/p>\n For further information, please contact:<\/p>\n Allmed Group<\/strong> Consilium Strategic Communications <\/strong> Allmed becomes the first fully MDR compliant haemodialysis product producer in Europe, the Middle East and Africa (EMEA) region Compliance with EU Medical Devices Regulation (MDR 2017\/745) certified by the British Standards Institution (BSI) auditing body LONDON, UK; 15 June, 2022 \u2013 Allmed Medical GmbH, part of Allmed Group (\u201cAllmed\u201d or \u201cthe Company\u201d), a producer [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\n\n
\n
\ninfo@allmedgroup.com<\/a>
\nTel: +44-20-8899-6450<\/p>\n
\nMatthew Neal\/ Davide Salvi\/ Lucie Foster
\nTel: +44(0)20-3709-5700
\nEmail: allmed@consilium-comms.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"